MDGL - Madrigal Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

MDGL is currently covered by 11 analysts with an average price target of $673.32. This is a potential upside of $219.98 (48.52%) from yesterday's end of day stock price of $453.34.

Madrigal Pharmaceuticals's activity chart (see below) currently has 262 price targets and 216 ratings on display. The stock rating distribution of MDGL is 85.71% BUY and 14.29% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 85.93% with an average time for these price targets to be met of 306.7 days.

Highest price target for MDGL is $964, Lowest price target is $510, average price target is $673.32.

Most recent stock forecast was given by ANDREA TAN from GOLDMAN SACHS on 24-Sep-2026. First documented stock forecast 12-Mar-2014.

Best performing analysts who are covering MDGL - Madrigal Pharmaceuticals:

Andrea Tan Jonathan Wolleben David Lebowitz Eliana Merle Akash Tewari

Currently out of the existing stock ratings of MDGL, 24 are a BUY (85.71%), 4 are a HOLD (14.29%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 19-Dec-2022

$704

$254.26 (56.53%)

$571

29 days ago
(24-Sep-2026)

5/7 (71.43%)

$190.79 (37.18%)

420

Hold Since 04-Aug-2026

$605

$155.26 (34.52%)

2 months 19 days ago
(04-Aug-2026)

2/3 (66.67%)

$97.44 (19.20%)

223

Buy Since 21-Dec-2022

$962

$512.26 (113.90%)

$964

2 months 20 days ago
(03-Aug-2026)

7/9 (77.78%)

$480 (99.59%)

287

Buy Since 30-Jan-2020

$587

$137.26 (30.52%)

$578

2 months 24 days ago
(29-Jul-2026)

18/20 (90%)

$40.12 (7.34%)

350

Buy Since 19-Oct-2017

$900

$450.26 (100.12%)

$900

3 months 24 days ago
(29-Jun-2026)

20/23 (86.96%)

$372.72 (70.69%)

299

Show more analysts

Please expand the browser size to see the chart

What is MDGL (Madrigal Pharmaceuticals) average time for price targets to be met?

On average it took 307 days for the stock forecasts to be reached, with an average price target met ratio of 85.93%.

Which analyst most recently updated their price target on MDGL (Madrigal Pharmaceuticals)?

Andrea Tan

Which analyst has the most public recommendations on MDGL (Madrigal Pharmaceuticals)?

Andrea Tan works at GOLDMAN SACHS and has 18 price targets and 12 ratings on MDGL

Which analyst is the currently most bullish on MDGL (Madrigal Pharmaceuticals)?

Eliana Merle with the highest potential upside of $512.26

Which analyst is the currently most reserved on MDGL (Madrigal Pharmaceuticals)?

Jim Birchenough with the lowest potential downside of -$483.23
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?